NATHANIEL BROCHU: Open Payments
NPI 1861585309 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,357 in 63 payments from 17 companies in 2025. Trend: 2023 $990 · 2024 $1,373 · 2025 $1,357
Food & beverage: $1,357
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 25 | $293 |
| Saluda Medical Americas, Inc. | 7 | $248 |
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $196 |
| PROTEGA PHARMACEUTIALS INC | 1 | $170 |
| Averitas Pharma Inc. | 4 | $97 |
| ABBVIE INC. | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| SPR Therapeutics, Inc | 4 | $44 |
| CATALYST PHARMACEUTICALS, INC. | 2 | $38 |
| Scilex Pharmaceuticals Inc. | 2 | $35 |
Products named: Evoke, Belbuca, ROXYBOND, XTAMPZA, QUTENZA, JOURNAVX, RELISTOR, SPRINT PNS System.
Industry payments across NY — which companies pay providers there.
